AveXis/Novartis: Bidder advised by Hogan Lovells, Freshfields Bruckhaus Deringer
09 APR 2018
Swiss drugmaker Novartis’ [VTX:NOVN] legal counsel in its proposed acquisition of AveXis [NASDAQ:AVXS], a clinical-stage gene therapy company, are Hogan Lovells and Freshfields Bruckhaus Deringer, said a person familiar with the matter.
Dyal Co is Novartis’s financial advisor, the person said.
AveXis’ financial advisors are Goldman Sachs and Centerview Partners. Cravath, Swaine and Moore and Cooley are acting as legal counsel for the target.
Novartis and Hogan Lovells declined to comment. Freshfields did not return a request for comment.